Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
Clinical trial NCT06902792 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06902792
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-06
- Primary completion
- 2025-08-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.